The Recall Desk

State

Washington product recalls

73,741 recalls have nationwide distribution and so reach Washington. 8,535 additional recalls listed Washington specifically in their distribution scope.

What the numbers show

Total
8,535
Critical
865
Severe
2,404
Most recent
2026-10-28

Of the 8,535 recalls naming Washington we have scored against our rubric, 865 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,404 (28%) are Severe.

These figures cover only the 8,535 recalls whose distribution notice names Washington specifically. The 73,741 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

36426–36450 of 82276

  • HighNHTSA·19V540000·2019-07-19

    Mercedes-Benz Recalls Vehicles for Radar Sensor Software Error

    Mercedes-Benz is recalling 2019-2020 vehicles because a software error in the radar sensor may impair Active Brake Assist, increasing crash risk.

    Product
    MERCEDES-BENZ — MERCEDES-BENZ CLS 450, C 300, E 450, E 300
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1465-2019·2019-07-17

    Losartan Potassium Tablets Recalled Due to NMBA Impurity Detection

    Golden State Medical Supply Inc. is recalling Losartan Potassium 100 mg tablets because an impurity called NMBA was detected in the active ingredient.

    Product
    Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1459-2019·2019-07-17

    Macleods Pharma Recalls Losartan Potassium and Hydrochlorothiazide Tablets Due to Impurity

    Macleods Pharma USA Inc. is recalling Losartan Potassium and Hydrochlorothiazide tablets because an impurity was detected in the active ingredient.

    Product
    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1477-2019·2019-07-17

    Methylcobalamin Injection Recalled for Lack of Sterility Assurance

    First Pharma Associates is recalling Methylcobalamin 1 mg/mL Injection vials due to a lack of assurance of sterility.

    Product
    Methylcobalamin 1 mg/mL Injection, 8 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1484-2019·2019-07-17

    Glutathione Inhalation Solution Recalled for Lack of Sterility Assurance

    First Pharma Associates is recalling specific vials of Glutathione 100 mg/mL Inhalation Solution due to a lack of assurance of sterility.

    Product
    Glutathione 100 mg/mL Inhalation Solution (PF), 45 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1483-2019·2019-07-17

    Riverpoint Pharmacy Recalls Chorionic Gonadotropin Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling specific vials of Chorionic Gonadotropin Injection due to a lack of assurance of sterility.

    Product
    Chorionic Gonadotropin 2,000U/mL PF Injection, 8 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1475-2019·2019-07-17

    Riverpoint Pharmacy Recalls Prostaglandin Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling Prostaglandin 20 mcg/mL/Procaine 0.1% Injection due to a lack of assurance of sterility.

    Product
    Prostaglandin 20 mcg/mL/Procaine 0.1% Injection, packaged in a) 2.5mL and b)10 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205 (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Devices)·Z-1770-2019·2019-07-17

    Becton Dickinson Recalls Alaris Pump Infusion Sets Due to Occlusion Defect

    Becton Dickinson is recalling Alaris Pump Infusion Sets because a wall thickness variation can cause incomplete occlusion, potentially leading to unintended or faster-than-expected medication delivery.

    Product
    Alaris Pump Infusion Set, Model Codes 10010453, 10010454, 10012144, 10015294, 10015414, 10933805, 11171447, 11404930, 11522558, 11607704, 10013361T, 2110-0500, 2126-0500, 2200-0500, 2411-0500, 2419-0007, 2420-0007, 2420-0500, 2421-0500, 2426-0007, 2426-0500, 2429-0500…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-1847-2019·2019-07-17

    GE Healthcare Recalls Panda Infant Radiant Warmers Due to Bedside Panel Cracking

    GE Healthcare is recalling 28,094 Panda Infant Radiant Warmers because the bedside panels and latch areas can crack or break if the unit is moved using them instead of the designated handles.

    Product
    Panda Infant Radiant Warmer Infant radiant warmers provide infrared heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. Infant radiant warmers may be used to facilitate the neonate's transition to the external environment…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1472-2019·2019-07-17

    Testosterone Cypionate Injection Recalled for Sterility Assurance Concerns

    First Pharma Associates is recalling Testosterone Cypionate 100 mg/mL oil injections due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    Testosterone Cypionate 100 mg/mLOil Injection Injection, 12 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1476-2019·2019-07-17

    Hydroxocobalamin Injection Recalled for Lack of Sterility Assurance

    First Pharma Associates is recalling Hydroxocobalamin 10 mg/mL Injection due to a lack of assurance of sterility. The product is distributed in Idaho and Washington.

    Product
    Hydroxocobalamin 10 mg/mL Injection (ALT) Solution, 30 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereNHTSA·19E045000·2019-07-17

    Reyco Fire Truck Front Suspension Recall for Shock Separation Risk

    Reyco is recalling Fire Truck Independent Front Suspensions because front shocks may separate and damage the steering gear, potentially causing a loss of power steering assist.

    Product
    SUSPENSION:FRONT recall
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1455-2019·2019-07-17

    Teva Recalls Losartan Potassium Tablets Due to Impurity Detection

    Teva Pharmaceuticals USA is recalling Losartan Potassium 50 mg tablets because an impurity was detected in the active ingredient.

    Product
    LOSARTAN POTASSIUM 50 mg TABLET BULK 90 count bottles and 1000 count bottles, NDC 00591-3746-00
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1460-2019·2019-07-17

    Macleods Pharma Recalls Losartan Potassium and Hydrochlorothiazide Tablets Due to Impurity

    Macleods Pharma USA Inc. is recalling Losartan Potassium and Hydrochlorothiazide tablets because an impurity was detected in the active pharmaceutical ingredient.

    Product
    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1481-2019·2019-07-17

    FDA Recalls Riverpoint Pharmacy Injection Due to Sterility Concerns

    First Pharma Associates LLC dba Riverpoint Pharmacy is recalling PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    PAP/PHEN/PGE1 30 mg/0.83mg/10mcg/mL Injection, 5 mL, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1466-2019·2019-07-17

    Major Pharmaceuticals Recalls Losartan Potassium Tablets Due to Impurity

    Major Pharmaceuticals is recalling Losartan Potassium 50 mg tablets because FDA testing found an impurity above acceptable levels.

    Product
    Losartan Potassium Tablets, USP. 50 mg. NDC# 0904-6390-61. Rx only. 100 count Unit Dose Cartons. Manufactured by Major Pharmaceuticals 17177 N. Laurel Park Drive Suite 233, Livonia, MI 48152.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1469-2019·2019-07-17

    Testosterone Cypionate Injection Recalled Due to Sterility Concerns

    First Pharma Associates is recalling Testosterone Cypionate 150 mg/mL Injection due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    Testosterone Cypionate 150 mg/mL Sesame Oil Injection, 12 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343- 6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1461-2019·2019-07-17

    Macleods Pharma Recalls Losartan Potassium and Hydrochlorothiazide Tablets Due to Impurity

    Macleods Pharma USA Inc. is recalling Losartan Potassium and Hydrochlorothiazide tablets because an impurity was detected in the active ingredient.

    Product
    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1480-2019·2019-07-17

    Riverpoint Pharmacy Recalls PAP/PHEN/PGE1 Injection Due to Sterility Concerns

    First Pharma Associates LLC dba Riverpoint Pharmacy is recalling specific lots of PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility.

    Product
    PAP/PHEN/PGE1 30 mg/2mg/20mcg/mL Injection, 10mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Devices)·Z-1923-2019·2019-07-17

    Philips HeartStart MRx Recall Due to AC Power Module Failure Risk

    Philips is recalling HeartStart MRx devices used with specific AC power modules that may fail, potentially causing loss of power and failure to deliver shocks.

    Product
    Philips HeartStart MRx devices in use with the M3539A AC Power Module: M3535A, M3536A, M3536M, M3536MC, M3536M2, M3536M3, M3536M4, M3536M5, M3536M6, M3536M7, M3536M8, M3536M9
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1473-2019·2019-07-17

    Riverpoint Pharmacy Recalls Testosterone Cyp/Estradiol Cyp Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling specific vials of Testosterone Cyp/Estradiol Cyp Injection because of a lack of assurance of sterility.

    Product
    Testosterone Cyp/Estradiol Cyp 50 mg/2.5 mg/mL Injection, 3mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Devices)·Z-1874-2019·2019-07-17

    Hamilton Medical Recalls HAMILTON-G5 Ventilators Due to Ambient State Risk

    Hamilton Medical is recalling 4,338 HAMILTON-G5 ventilators with software versions 2.60 or lower because they may enter an ambient state, requiring immediate alternative ventilation.

    Product
    HAMILTON-G5, with software versions less than or equal to 2.60 The HAMILTON-G5/S1 ventilators are designed for intensive care ventilation of adult and pediatric patients, and optionally infant and neonatal patients. The device is intended for use in the hospital and…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1462-2019·2019-07-17

    Losartan Potassium Tablets Recalled Due to Impurity Detection

    Golden State Medical Supply Inc. is recalling Losartan Potassium 50 mg tablets because an impurity was detected in the active ingredient.

    Product
    Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30
    Category
    Drug
    Distribution
    Distributed nationwide